News Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Real-time Estimate Cboe BZX Other stock markets 09:59:08 2024-04-26 am EDT			5-day change	1st Jan Change
12.54 ^USD	+2.20%		+4.20%	+39.33%

02:08pm	Seaport Global Starts Hims & Hers Health With Buy Rating	MT
Apr. 16	Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seaport Global Starts Hims & Hers Health With Buy Rating	08:08am	MT
Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17	Apr. 16	MT
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024	Apr. 15	BU
Canaccord Genuity Initiates Coverage on Hims & Hers Health With Buy Rating, $20 Price Target	Apr. 10	MT
Hims & Hers Appoints Christopher Payne as Newest Board Member	Apr. 03	CI
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member	Apr. 03	BU
Hims & Hers Health Insider Sold Shares Worth $823,055, According to a Recent SEC Filing	Mar. 22	MT
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing	Mar. 15	MT
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024	Mar. 11	BU
Hims & Hers Health Insider Sold Shares Worth $500,107, According to a Recent SEC Filing	Mar. 08	MT
Hims & Hers Health Insider Sold Shares Worth $685,288, According to a Recent SEC Filing	Mar. 05	MT
Hims & Hers Health Insider Sold Shares Worth $5,032,142, According to a Recent SEC Filing	Mar. 04	MT
Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating	Mar. 01	MT
Hims & Hers Health Shares Jump After Q4 Beat	Feb. 27	MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $11 From $9, Maintains Neutral Rating	Feb. 27	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $14 From $8, Maintains Hold Rating	Feb. 27	MT
Thinking about buying stock in Infobird, PubMatic, Hims & Hers Health, FibroGen, or Alpha Metallurgical Resources?	Feb. 27	PR
Truist Securities Adjusts Price Target on Hims & Hers Health to $13 From $10, Keeps Hold Rating	Feb. 27	MT
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Tuesday; Hims & Hers Health Set to Gain, Intuitive Machines to Decline	Feb. 27	MT
Transcript : Hims & Hers Health, Inc., Q4 2023 Earnings Call, Feb 26, 2024	Feb. 26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Summary

Filters